autologous transplantation

Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

Related to autologous transplantation: allogeneic transplantation, Stem cell transplant

autologous transplantation,

autotransplantation.

autologous transplant

A generic term for the administration of tissues or cells, in particular bone marrow, which had been removed before high-dose chemo- and/or radiotherapy.

au·tol·o·gous trans·plan·ta·tion

(aw-tol'ŏ-gŭs trans'plan-tā'shŭn)

Transplant involving one person as both donor and recipient.

Autologous transplantation

A procedure wherein the person donates blood or tissue to themselves.

Mentioned in: Vitiligo

Mentioned in ?

References in periodicals archive ?

In other solid tumors, the patients may benefit from autologous transplantation in presence of the following special conditions (24):

Hematopoetic stem cell transplantation in children

Boccadoro M, Cavallo F, Nagler A, Ben Yehuda D, Omede P, Cavalli M, Levi A, Crippa C, Siniscalchi A, Brasca P, Carella AM, Zanetti BA, Patriarca F, Pezzati S, Montefusco V, Stanevsky A, Lupo B, Caravita T, Di Raimondo F, Palumbo AR Melphalan/prednisone/lenalidomide (MPR) versus high-dose melphalan and autologous transplantation (MEL200) in newly diagnosed multiple myeloma (MM) patients: a phase III trial.

Is there an optimal timing of autologous stem-cell transplantation for multiple myeloma in the era of novel agents? / Yeni ilaclarin Doneminde, Multiple Myelomada Kok Hucre Nakli icin Uygun Bir Zamanlama Var midir?

However, this was invalid for autologous transplantations, because the TRM rate in the auto-HSCT patients was much higher than acceptable thresholds.

Hematopoietic stem cell transplantation activity and trends at a pediatric transplantation center in Turkey during 1998-2008 / 1998-2008 Yillari Arasinda Turkiye'de bir Pediatrik Nakil Merkezindeki Hematopoietik Kok Hucre Nakli Aktiviteleri ve Egilimleri

Discovering this novel, autologous transplantation method, where there is no rejection.

Researchers grown arteries inside patient's body

The authors theorize that a delay between the onset of complete remission and the initiation of post-remission treatment might account for the failure of autologous transplantation to improve survival.

Autologous bone marrow transplants offer no survival advantage for patients with AML, study finds

The committee endorsed the company's data, suggesting that adding Stemgen to Neupogen in patients undergoing autologous transplantation increased the proportion of patients able to reach a target number of stem cells to permit transplantation and that the risk/benefit ratio supports the indication.

FDA advisory panel recommends approval of Amgen's blood cell growth factor, Stemgen